Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0N1VG
|
|||
| Former ID |
DNCL003192
|
|||
| Drug Name |
DeNVax
|
|||
| Indication | Dengue fever [ICD-11: 1D2Z; ICD-10: A97, A97.9; ICD-9: 61] | Phase 2 | [1], [2] | |
| Company |
Inviragen
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01511250) Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine in Healthy Volunteers Between the Ages of 1.5 - 45 Years. U.S. National Institutes of Health. | |||
| REF 2 | Genetic and phenotypic characterization of manufacturing seeds for a tetravalent dengue vaccine (DENVax). PLoS Negl Trop Dis. 2013 May 30;7(5):e2243. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.